Vanda Pharmaceuticals
VNDA
VNDA
180 hedge funds and large institutions have $947M invested in Vanda Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 74 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less call options, than puts
Call options by funds: $2.07M | Put options by funds: $2.57M
20% less capital invested
Capital invested by funds: $1.18B → $947M (-$232M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
180
Holding in Top 10
1
Calls
$2.07M
Puts
$2.57M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$6.02M | |
| 3 | +$5.12M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$4.78M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.05M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$3.67M | |
| 3 | -$3.06M | |
| 4 |
BlackRock
New York
|
-$2.82M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.3M |